Life Healthcare stock last traded at EUR 0.62 as EBITDA rose 5.70 percent

Life Healthcare stock last traded at EUR 0.62 on Tradegate on September 24, 2026, while the group's 11-month update showed normalised EBITDA growth of 5.70 percent through August 31, 2026. The figures point to an earnings-quality improvement driven by operating efficiency rather than fast top-line expansion.

EBITDA outpaces revenue growth

According to Sharenet on September 11, 2026, revenue growth for the review period was 1.70 percent, while normalised EBITDA increased 5.70 percent versus the prior review period. The 4.00 percentage point gap between the two growth rates is the central operating signal for investors.

The southern Africa normalised EBITDA margin improved by 60 basis points compared with the prior review period, according to the same dated company update. Life Healthcare attributed the progress to cost-saving measures and operating efficiencies, creating margin expansion while revenue growth stayed constrained by funder-related disruption and an unfavorable case mix.

Occupancy clears revised guidance

Weighted average occupancy reached 69.50 percent during the 11-month period, exceeding the revised full-year guidance of 68.00 percent. Paid patient days grew 0.20 percent for the review period, with complementary services delivering 3.20 percent growth and second-half paid patient days increasing 0.80 percent.

The update also reported net recruitment of 120 specialist doctors and identified the planned 140-bed Life Paarl Valley Hospital as part of the group's FY2026 strategic commitments. Reuters describes Life Healthcare as a South Africa-based diversified healthcare provider with acute care and complementary services, including mental health, rehabilitation, renal dialysis, oncology, diagnostics and nuclear medicine, as reported on September 23, 2026 by Reuters.

Stock valuation and trading context

Life Healthcare's JSE quote stood at ZAc 1,181.00 on September 29, 2026 at 4:34 p.m. SAST, up 0.60 percent from the prior JSE session. The 52-week JSE range was ZAc 1,000.00 to ZAc 1,302.00, placing the quote 9.29 percent below the high. Market capitalization stood at ZAR 16.9 billion on September 29, 2026.